human | Q5 |
P496 | ORCID iD | 0000-0002-6952-9338 |
P4789 | Who's Who UK ID | U290044 |
P512 | academic degree | Doctor of Philosophy | Q752297 |
P166 | award received | Fellow of the Royal Society | Q15631401 |
P108 | employer | Pirbright Institute | Q6039151 |
P735 | given name | Bryan | Q3894860 |
Bryan | Q3894860 | ||
P106 | occupation | researcher | Q1650915 |
microbiologist | Q3779582 | ||
P21 | sex or gender | male | Q6581097 |
Q71566470 | A novel uterine protein that associates with the embryonic capsule in equids |
Q40190560 | A replication-competent foot-and-mouth disease virus expressing a luciferase reporter. |
Q39542454 | Accumulation of nucleotide substitutions occurring during experimental transmission of foot-and-mouth disease virus. |
Q30388110 | Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus. |
Q27472937 | Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo. |
Q45397140 | An MHC-restricted CD8+ T-cell response is induced in cattle by foot-and-mouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. |
Q36673744 | An interferon-induced Mx protein: cDNA sequence and high-level expression in the endometrium of pregnant sheep. |
Q42678559 | Analysis of the repertoire of cattle CD4(+) T cells reactive with bovine viral diarrhoea virus. |
Q38784217 | Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation. |
Q35576469 | Aspects of the innate and adaptive immune responses to acute infections with BVDV |
Q36367906 | Assessment of T-dependent and T-independent immune responses in cattle using a B cell ELISPOT assay |
Q81288321 | Assessment of the efficacy of tilmicosin as a treatment for Mycoplasma gallisepticum infections in chickens |
Q41154969 | Assessment of the enhancement of PLGA nanoparticle uptake by dendritic cells through the addition of natural receptor ligands and monoclonal antibody |
Q27478375 | Bovine Viral Diarrhea Virus: Prevention of Persistent Fetal Infection by a Combination of Two Mutations Affecting Erns RNase and Npro Protease |
Q35076844 | Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo. |
Q43000630 | Bovine viral diarrhoea virus: its effects on ovarian function in the cow. |
Q40963680 | Bovine γδ T cells are a major regulatory T cell subset. |
Q42699658 | CD4+ T-cell responses to foot-and-mouth disease virus in vaccinated cattle. |
Q38936078 | Cattle remain immunocompetent during the acute phase of foot-and-mouth disease virus infection. |
Q42666963 | Characterization of epitope-tagged foot-and-mouth disease virus |
Q58747407 | Chimeric O1K foot-and-mouth disease virus with SAT2 outer capsid as an FMD vaccine candidate |
Q36548980 | Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever |
Q39855667 | Clinical and laboratory investigations of the outbreaks of foot-and-mouth disease in southern England in 2007. |
Q54226450 | Comparison of Heterosubtypic Protection in Ferrets and Pigs Induced by a Single-Cycle Influenza Vaccine. |
Q93503777 | Comparison of the efficacies of three fluoroquinolone antimicrobial agents, given as continuous or pulsed-water medication, against Escherichia coli infection in chickens |
Q47548484 | Detection of Pathogen Exposure in African Buffalo Using Non-Specific Markers of Inflammation |
Q34057878 | Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses. |
Q36878914 | Differential Persistence of Foot-and-Mouth Disease Virus in African Buffalo Is Related to Virus Virulence. |
Q35192675 | Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo. |
Q30394336 | Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09 |
Q36572854 | Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity |
Q43032855 | Establishment of persistent infection with non-cytopathic bovine viral diarrhoea virus in cattle is associated with a failure to induce type I interferon. |
Q37866385 | Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus. |
Q40343205 | Experimental acute infection of alpacas with Bovine viral diarrhea virus 1 subgenotype b alters peripheral blood and GALT leukocyte subsets |
Q40123532 | Fibrinogen is localized on dark zone follicular dendritic cells in vivo and enhances the proliferation and survival of a centroblastic cell line in vitro. |
Q43153250 | Foot-and-mouth disease virus can induce a specific and rapid CD4+ T-cell-independent neutralizing and isotype class-switched antibody response in naïve cattle. |
Q34741667 | Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. |
Q27438168 | Foot-and-mouth disease virus persists in the light zone of germinal centres |
Q39034584 | Frequency and phenotype of natural killer cells and natural killer cell subsets in bovine lymphoid compartments and blood. |
Q87360246 | GUEST EDITORIAL - The importance of sound experimental design and analysis |
Q42999007 | Germinal centre localization of bovine viral diarrhoea virus in persistently infected animals. |
Q36663758 | Global FMD control--is it an option? |
Q38869889 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 1 - Overview of Global Status and Research Needs |
Q38851221 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 2 - Epidemiology, Wildlife and Economics. |
Q38851217 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines |
Q38851213 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 4 - Diagnostics. |
Q38851209 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 5 - Biotherapeutics and Disinfectants |
Q38851205 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 6 - Immunology |
Q38851202 | Global Foot-and-Mouth Disease Research Update and Gap Analysis: 7 - Pathogenesis and Molecular Biology. |
Q34738862 | Hsp110-mediated enhancement of CD4+ T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivo |
Q33701133 | Hsp70 enhances presentation of FMDV antigen to bovine CD4+ T cells in vitro. |
Q36949946 | Identification of Salmonella enterica serovar Dublin-specific sequences by subtractive hybridization and analysis of their role in intestinal colonization and systemic translocation in cattle |
Q27469811 | Identification of a cell population that produces alpha/beta interferon in vitro and in vivo in response to noncytopathic bovine viral diarrhea virus. |
Q45403428 | Identification of a novel foot-and-mouth disease virus specific T-cell epitope with immunodominant characteristics in cattle with MHC serotype A31. |
Q34199805 | Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes |
Q42989301 | Immunohistochemical evidence for the localization of bovine viral diarrhea virus, a single-stranded RNA virus, in ovarian oocytes in the cow. |
Q30429455 | Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine |
Q42375439 | Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination. |
Q54109159 | Induction of influenza-specific local CD8 T-cells in the respiratory tract after aerosol delivery of vaccine antigen or virus in the Babraham inbred pig. |
Q45024291 | Infection of cattle with Theileria parva induces an early CD8 T cell response lacking appropriate effector function. |
Q59240960 | Influence of the nature of the antigen on the boosting of responses to mycobacteria in M. bovis-BCG vaccinated cattle |
Q45423150 | Interferon-gamma production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV. |
Q40061913 | Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control. |
Q34366399 | Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity |
Q57098605 | Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve |
Q44537139 | Massive, sustained gammadelta T cell migration from the bovine skin in vivo |
Q95824285 | Massive, sustained γδ T cell migration from the bovine skin in vivo |
Q47571977 | Migratory sub-populations of afferent lymphatic dendritic cells differ in their interactions with Mycobacterium bovis Bacille Calmette Guerin. |
Q34170015 | Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response. |
Q45357184 | Modelling the within-host dynamics of the foot-and-mouth disease virus in cattle. |
Q35943471 | Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation. |
Q43036793 | Modulation of sex hormone secretion in cows by acute infection with bovine viral diarrhoea virus. |
Q35799818 | Mycobacterium bovis shedding patterns from experimentally infected calves and the effect of concurrent infection with bovine viral diarrhoea virus |
Q36852321 | Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle |
Q42991493 | Prolonged nasal shedding and viraemia of cytopathogenic bovine virus diarrhoea virus in experimental late-onset mucosal disease. |
Q40380624 | Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation |
Q27677139 | Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen |
Q52650429 | Recent advances in veterinary applications of structural vaccinology. |
Q74508110 | Regulation of MHC class I gene expression is at transcriptional and post-transcriptional level in bovine placenta |
Q51571274 | Relationship between clinical signs and transmission of an infectious disease and the implications for control. |
Q30854552 | Rules of engagement between αvβ6 integrin and foot-and-mouth disease virus |
Q38744534 | SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability |
Q90912985 | Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats |
Q27702186 | Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design |
Q33295285 | Systemic translocation of Salmonella enterica serovar Dublin in cattle occurs predominantly via efferent lymphatics in a cell-free niche and requires type III secretion system 1 (T3SS-1) but not T3SS-2 |
Q91658607 | Tackling human and animal health threats through innovative vaccinology in Africa |
Q38947438 | The B Cell Response to Foot-and-Mouth Disease Virus in Cattle following Sequential Vaccination with Multiple Serotypes |
Q38766380 | The B-cell response to foot-and-mouth-disease virus in cattle following vaccination and live-virus challenge. |
Q52567742 | The MHC homozygous inbred Babraham pig as a resource for veterinary and translational medicine. |
Q40065557 | The Npro product of classical swine fever virus and bovine viral diarrhea virus uses a conserved mechanism to target interferon regulatory factor-3. |
Q33352440 | The Npro product of classical swine fever virus interacts with IkappaBalpha, the NF-kappaB inhibitor. |
Q28115637 | The classical swine fever virus N-terminal protease N(pro) binds to cellular HAX-1 |
Q39775972 | The classical swine fever virus Npro product is degraded by cellular proteasomes in a manner that does not require interaction with interferon regulatory factor 3. |
Q24320429 | The developmental regulation of a novel muscle LIM-protein |
Q42040556 | The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus. |
Q84203753 | The importance of FMDV localisation in lymphoid tissue |
Q35091556 | The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species |
Q36177341 | The role of dendritic cells in shaping the immune response. |
Q54217589 | Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors. |
Q40574579 | Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway |
Q38780088 | Type I and III IFNs Produced by Plasmacytoid Dendritic Cells in Response to a Member of the Flaviviridae Suppress Cellular Immune Responses. |
Q38222524 | Type I and III interferon production in response to RNA viruses. |
Q45365192 | Understanding foot-and-mouth disease virus early pathogenesis and immune responses. |
Q37027760 | Understanding foot-and-mouth disease virus transmission biology: identification of the indicators of infectiousness. |
Q58830787 | Universal detection of foot and mouth disease virus based on the conserved VP0 protein |
Q74277605 | Use of colostrum from rotavirus-immunised cows as a single feed to prevent rotavirus-induced diarrhoea in calves |
Search more.